.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cerilliant
QuintilesIMS
US Department of Justice
Farmers Insurance
UBS
Deloitte
Dow
Medtronic
Express Scripts

Generated: December 17, 2017

DrugPatentWatch Database Preview

PROAIR HFA Drug Profile

« Back to Dashboard

Which patents cover Proair Hfa, and when can generic versions of Proair Hfa launch?

Proair Hfa is a drug marketed by Teva Branded Pharm and is included in one NDA. There are six patents protecting this drug.

This drug has two hundred and thirty patent family members in twenty-eight countries.

The generic ingredient in PROAIR HFA is albuterol sulfate. There are thirty-seven drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROAIR HFA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004► Subscribe► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004► Subscribe► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004► Subscribe► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004► Subscribe► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004► Subscribe► Subscribe
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: PROAIR HFA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,526,850Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
6,743,413 Suspension aerosol formulations► Subscribe
9,526,851Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,533,111Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,216,260Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,108,010Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,731,087Dose counter for inhaler having a bore and shaft arrangement► Subscribe
9,174,013Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,737,674Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
8,978,966Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PROAIR HFA

Country Document Number Estimated Expiration
Eurasian Patent Organization026217► Subscribe
Japan2014144353► Subscribe
Eurasian Patent Organization201300237► Subscribe
New Zealand246421► Subscribe
Austria215359► Subscribe
European Patent Office2502644► Subscribe
Denmark2135199► Subscribe
Denmark2502644► Subscribe
Japan5246968► Subscribe
Japan2004143183► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Deloitte
US Army
Queensland Health
Chinese Patent Office
Covington
Citi
Farmers Insurance
Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot